![Brand Engagement Network Inc](/common/images/company/N_BNAI.png)
BEN is Focused on Delivering Personalized Customer Engagement by Harnessing the Power and Scalability of AI.BEN Provides a Human-Like interface and a safe environment through multi-modal communication, delivering scaled solutions for industries impacted by labor and cost burdens and a desire to incr... BEN is Focused on Delivering Personalized Customer Engagement by Harnessing the Power and Scalability of AI.BEN Provides a Human-Like interface and a safe environment through multi-modal communication, delivering scaled solutions for industries impacted by labor and cost burdens and a desire to increase engagement with their clients.BEN¿s mission is to create the best AI Assistant for people around the world. We strive to make our AI Assistants Helpful, Creative, Clever, and Friendly. Show more
Full US use of ANDiS 350 extraction systems would increase US daily testing capacity by 25% 3D Med extraction capacity increased by 1,000,000 kits per week Extraction reagent and automation...
Amarantus Acquires Majority Interest in CBD Wellness Company Hempori Strong customer retention at both stores in Dallas, TX with growing online presence Focus...
Amarantus Sub Elto Pharma Gets Notice of Allowance Covering Use of Eltoprazine Combined with CBD to Treat Parkinson’s Disease Patent extends patent coverage for eltoprazine to...
Amarantus Enters Into Agreement to License Diverse Therapeutics Portfolio to CBD-focused Emerald Organic Products Amarantus is receiving Emerald Preferred Stock with a minimum value of...
Amarantus Engages Evolution Venture Partners to Evaluate Strategic Alternatives for Expansion into the Legal Hemp Industry New York, NY -- May 28, 2019 -- InvestorsHub NewsWire...
Amarantus Provides 2019 Roadmap New York, NY -- January 7, 2019 -- InvestorsHub NewsWire -- Amarantus Bioscience Holdings, Inc. (OTC Pink: AMBS) (the...
Coeptis Pharma Enters into Agreement to Acquire Elto Pharma New York, NY and Wexford, PA -- November 28, 2018 -- InvestorsHub NewsWire -- Coeptis...
Amarantus Provides Corporate Update New York, NY -- July 20, 2018 -- InvestorsHub NewsWire -- Amarantus Bioscience Holdings, Inc. (OTC Pink: AMBS) (the...
MANF Therapeutics Announces Positive MANF Pre-Clinical Data in Alpha-Synuclein Model of Parkinson's Disease Published in Peer-Reviewed Journal Experimental...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.39 | -48.4320557491 | 2.87 | 3.1 | 1.35 | 139247 | 2.16237839 | CS |
4 | -1.5 | -50.3355704698 | 2.98 | 3.74 | 1.35 | 103065 | 2.7846653 | CS |
12 | 0.06 | 4.22535211268 | 1.42 | 8.43 | 0.99 | 3642373 | 3.74506136 | CS |
26 | -4.37 | -74.7008547009 | 5.85 | 19.75 | 0.99 | 2182877 | 3.79149312 | CS |
52 | -4.37 | -74.7008547009 | 5.85 | 19.75 | 0.99 | 2182877 | 3.79149312 | CS |
156 | -4.37 | -74.7008547009 | 5.85 | 19.75 | 0.99 | 2182877 | 3.79149312 | CS |
260 | -4.37 | -74.7008547009 | 5.85 | 19.75 | 0.99 | 2182877 | 3.79149312 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.